Languages  By theme  By sector  By country
Page : 1 - 2 - ... 8 - 9 - 10 - 11 - 12 - 13 - 14 - ...
Hardman & Co Research [GB00BYYW9G87]   
[17/09/2020]

Hardman & Co Research : Hardman & Co Research: City of London Investment Group (CLIG): Solid results, with surprise dividend increase

Hardman & Co Research Hardman & Co Research: City of London Investment Group CLIG: Solid results, with surprise dividend increase 17Sep2020 / 14:40 GMT/BST Hardman & Co Research: Solid results, with surprise dividend increase City of London has announced its fullyear results for FY20. As previously indicated, over a volatile year, FUM grew to $5.51bn. This led to a 4% increase in fee... See more
 
The Vanguard Group, Inc. [US12572Q1058]   
[17/09/2020]

The Vanguard Group, Inc. : Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc

The Vanguard Group, Inc. IRSH Form 8.3 The Vanguard Group, Inc.: Willis Towers Watson plc 17Sep2020 / 14:39 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Ap19   FORM 8.3   IRISH TAKEOVER PANEL   DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,... See more
 
The Vanguard Group, Inc. [US12572Q1058]   
[17/09/2020]

The Vanguard Group, Inc. : Form 8.3 - The Vanguard Group, Inc.: Aon plc

The Vanguard Group, Inc. IRSH Form 8.3 The Vanguard Group, Inc.: Aon plc 17Sep2020 / 14:35 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Ap19   FORM 8.3   IRISH TAKEOVER PANEL   DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES,... See more
 
Maitland Institutional Services Limi [JE00B3DG9318]   
[17/09/2020]

Maitland Institutional Services Limited : Form 8.3 - SDL Plc

Maitland Institutional Services Limited MISL Form 8.3 SDL Plc 17Sep2020 / 14:15 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3... See more
 
TESSI [FR0004529147/TES]   
[17/09/2020]

TESSI : Déclaration des droits de vote au 31 août 2020

Déclaration mensuelle des droits de vote – 31 août 2020 Publication du nombre d'actions composant le capital et du nombre total de droits de vote articles L. 2338 II du code de commerce et 22316 du règlement général de l'AMF. Date d'arrêt des informations Nombre total d'actions composant le capital Nombre total de droits de vote 31 août 2020 3 259... See more
 
Chelverton Small Companies Dividend [GB0006615826]   
[17/09/2020]

Chelverton Small Companies Dividend Trust PLC : Chelverton UK Dividend Trust plc: Net Asset Value(s)

Chelverton UK Dividend Trust plc SDVP Chelverton UK Dividend Trust plc: Net Asset Values 17Sep2020 / 13:34 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Chelverton UK Dividend Trust PLC The Company announces: Total Assets including unaudited revenue reserves at... See more
 
Fullers Smith & Turner PLC [GB00B1YPC344]   
[17/09/2020]

Fullers Smith & Turner PLC : Fuller, Smith & Turner PLC: PDMR Shareholding

Fuller, Smith & Turner PLC FSTA Fuller, Smith & Turner PLC: PDMR Shareholding 17Sep2020 / 13:32 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. Fuller, Smith & Turner P.L.C. the \Company\     Notification and public disclosure of transactions by persons discharging... See more
 
Hardman & Co Research [GB00BYYW9G87]   
[17/09/2020]

Hardman & Co Research : Hardman & Co Research: Diurnal Group (DNL): Closely watching the regulators

Hardman & Co Research Hardman & Co Research: Diurnal Group DNL: Closely watching the regulators 17Sep2020 / 12:40 GMT/BST Hardman & Co Research: Closely watching the regulators Diurnal is a commercialstage specialty pharmaceutical company focused on diseases of the endocrine system. Its products are targeting rare conditions where medical need is currently unmet, with the longterm aim... See more
 
Page : 1 - 2 - ... 8 - 9 - 10 - 11 - 12 - 13 - 14 - ...
Videos
Gestionnaires,
Emetteurs,
My favourite companies
Most read news
Dissemination technology Webdisclosure.com - copyright 2020 SYMEX ECONOMICS all rights reserved